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stem cells in endometrial cancer. Jain and Jackson (4) present a 
hybrid model that simulates the dynamics of vascular endothelial 
growth factor (VEGF) diffusion and its binding to endothelial cell 
receptors, which triggers endothelial cell activation and polarization 
during angiogenesis. Finley et al. (5) consider another angiogen-
esis model centered on VEGF and its molecular interactions that 
has been calibrated to experimental data and shows that in vivo 
VEGF secretion rates are significantly lower than most reported 
in vitro measurements, which has profound implications for anti-
angiogenic treatment.
The second class of papers contains mechanical models of 
tumor invasion that are influenced by both the physical forces 
and chemical factors necessary to degrade the host tissue. Deakin 
and Chaplain (6) present a mathematical model focusing on both 
soluble and membrane-bound metalloproteinases (MMPs) and 
their relative role in the degradation of highly dense collagen struc-
tures and cross-linked fibers. Mumenthaler et al. (7) discuss an 
integrative experimental–computational approach to understand 
MMP-mediated tissue degradation. The fluid-generated forces 
exerted on the cell either by the interstitial fluid or shear stress 
in the blood circulation are reviewed by Mitchell and King (8) 
from both experimental and computational perspectives. Katira 
et al. (9) discuss interdependence of mechanical and biological 
pathways within the cell and how intracellular and environmen-
tal mechanical properties, such as stiffness and adhesivity, lead to 
changes in cell behavior, including transformation into malignancy. 
Wallace and Guo (10) analyze mathematical models of avascular 
tumor growth and conditions under which the models reproduce 
the growth dynamics of in vitro spheroids.
The third group of studies investigates cancer stem cells. With 
experimental stem cell purification and reliable identification still 
in its infancy, mathematical models highlight the population-level 
dynamics resulting from different stem cell kinetics. Rodriguez-
Brenes et al. (11) discuss homeostasis in stem cell lineages through 
tightly controlled feedback mechanisms that regulate stem cell 
proliferation and self-renewal. Enderling et al. (12) examine how 
tumors grow if the cancer population is fueled by a cancer stem cell, 
showing that tumors exhibit a variety of irregular morphologies 
and harbor stem cell fractions that vary by many orders of magni-
tude and evolve over time. Bachman and Hillen (13) investigate how 
conventional radiotherapy can be complemented by differentiation 
therapy that forces stem cells into differentiation to increase their 
sensitivity to radiation.
Cancer is one of the deadliest diseases of our time. While the war on 
cancer has cost many billions of dollars, the mechanisms underlying 
tumor development, progression, and therapeutic cure or control 
are yet to be fully understood. An interdisciplinary effort that brings 
together clinicians and biologists with mathematical and computa-
tional modelers is therefore necessary. Mathematical modeling and 
computational simulations bring to the table sophisticated tools 
for analyzing experimental data as well as for systematic, quanti-
tative, and multi-scale in silico experimentation. Taken together, 
such an interdisciplinary approach promises to shed light on the 
underlying rules of the intra-, inter-, and extracellular mechanisms 
behind complex tumor dynamics, with the ultimate aim to predict 
patient-specific treatment outcomes.
The papers in this Special Topic span a broad spectrum of can-
cer cell-related subjects from intracellular modifications in indi-
vidual cells to complex interactions between tumor cells and tumor 
microenvironments to emerging behaviors of cell populations on 
the organ and whole body scale. Quantitative modeling has been 
applied to virtually every type of tumor. This collection includes 
papers on brain, ovarian, and colon cancers, as well as on melano-
mas, leukemias, sarcomas, and head and neck tumors. The models 
also addressed various stages of tumor development including its 
initiation, growth, invasion of the surrounding stroma, tumor cell 
migration, and intravascular transport, as well as metastatic colo-
nization. Various types of anticancer treatments have been dis-
cussed in this Special Topic, including chemotherapy, radiotherapy, 
immunotherapy, and differentiation therapy. From a mathematical 
point of view, the models range from deterministic to stochastic, 
from continuous population dynamics to agent-based individual 
cell models, from fluid dynamics to Monte Carlo simulations and 
energy minimization models.
We divided the papers in this Special Topic into five categories. 
In the first, the subcellular mechanisms and their impact on a single 
cell and population-level heterogeneity are considered. Dynamics 
on the subcellular scale include intracellular gene modulations or 
extracellular diffusion of soluble factors. Leenders and Tuszynski 
(1) discuss both stochastic and deterministic models of p53 protein 
regulation that play a crucial role in cellular stress and DNA damage 
response. Kimmel and Corey (2) show that large variations in the 
timing of transitions from neutropenia to acute myeloid leukemia 
can be explained by stochasticity in cell driver mutations. Howk 
et al. (3) use a single cell model of two-hit mutations of normal 
cells into endometrial cancer cells to predict the frequency of cancer 
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The next group of articles focuses on interactions between the 
tumor and its microenvironment. Szabó and Merks (14) discuss 
avascular and vascular tumor growth and evolution using the 
Cellular Potts model. Orlando et al. (15) examine tumor cell evo-
lution at the tumor core and its invasive edge, focusing on the effects 
of colonization tradeoffs on tumor invasion dynamics. Steinkamp 
et al. (16) integrate in vivo xenograft mouse models and mathemati-
cal models to study tumor attachment, invasion, and vasculariza-
tion in the ovary, showing that local factors and mesothelial lining 
features strongly influence invasion.
The final group of studies focuses on the use of quantitative 
models to improve treatment modalities. Patient-specific math-
ematical neuro-oncology approaches are reviewed by Baldock 
et al. (17). Kim (18) presents a mathematical model based on 
microRNAs that balance cell proliferation and migration in dif-
ferent microenvironmental conditions in glioblastoma, suggest-
ing a post-surgery injection of chemoattractants and glucose to 
counteract the diffusive spread of residual cells. Hawkins-Daarud 
et al. (19) discuss a model of fluid accumulation in gliomas during 
anti-angiogenic therapy and discuss the implications of the envi-
ronmental response to tumor growth on medical imaging. Rejniak 
et al. (20) present an integrative study examining penetration and 
efficacy of therapeutic agents in relation to tumor tissue archi-
tecture. DePillis et al. (21) use a model of dendritic cell therapy 
on melanoma, showing how dosage and schedule modifications 
enhance immunotherapy efficacy.
The images featured on page 2 of this e-book showcase compu-
tational models discussed in detail in this Special Topic. Clockwise 
from top left: a schematic of miR-451 activity in the model of Kim 
(18); a 2-D slice through the ovarian tumor simulated using the 
Potts model of Steinkamp et al. (16); a 3-D simulation of malignant 
glioma cells from Baldock et al. (17); cancer stem cell-driven tumor 
growth from Enderling et al. (12).
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